Introduction
Genital chlamydia infection is the most prevalent bacterial sexually transmitted disease (STD)' and may lead to serious complications in men and women. Infants may also be affected at birth through vertical transmission. The most severe complications include epididymitis,2 salpingitis, infertility3 and infant pneumonia.4The epidemiology of genital chlamydia infection is imperfectly understood, although it appears to differ from that of gonorrhoea and other STD.5 Chlamydia cases were younger and more likely to be white than gonorrhoea patients, geographic overlap of the two diseases was only about 40%, with chlamydia being more diffusely distributed, and gonococcal coinfection occurred in less than 10% of chlamydia patients.5 Consequently it is not clear which groups should be targeted for health promotional activities or other control strategies. In particular, screening of sexually active women for chlamydia has been proposed as a useful public health strategy for controlling disease. 6 However, in some settings it may be impractical to screen all women (for example, in general practice) and in others (such as low prevalence populations) widespread screening may not be cost effective. Appropriate guidelines for selective screening might overcome these constraints. To provide this information all women attending a major STD clinic in a 3 year period were offered screening for chlamydia and gonorrhoea, and the test results correlated with a wide range of potential predictors.
Methods
From 1988-1990 all sexually active women attending the Adelaide STD clinic (Clinic 275) were offered testing for chlamydia (using the Pharmacia enzyme immunoassay test) and gonorrhoea (by smear and culture of endocervical specimens). After cleansing the cervix of external exudate or vaginal secretions, a cotton swab was inserted 2 cms into the external os and rotated to obtain a specimen for smear preparation and gonococcal culture.
A cotton swab on a metal shaft was then inserted into the endocervical canal and rotated firmly for 5-10 seconds. The swab was then inserted into a transport tube, the metal shaft snapped and the sealed tube sent directly to the laboratory for chlamydia antigen assay.
Specimens for gonococcal isolation were plated directly onto Oxoid modified NewYork City medium (lysed horse blood base with nutrient enrichment and antimicrobial inhibitors) and incubated at 35°C in an atmosphere containing 5% carbon dioxide. Colonies showing typical gonococcal morphology were confirmed as gonococci by Gram stain smear, oxidase reaction, sugar utilisation tests and coagglutination using the Phadebact monoclonal gc test kit (Karo Bio Diagnostics).
Demographic information, history, examination and laboratory findings were recorded in a standardized categorical format.8 At the conclusion of each episode of infection data were entered into an NEC Powermate computer using "dBase III plus" software. Quality control mechanisms to maximise completeness and accuracy of data included independent checking for completeness at the time of patient attendance, checking of data at the end of each episode for accurate coding and consistency, and computerized consistency checks at the time of data entry. At the end of each year computer files were subjected to consistency analysis, and aberrant casenotes were reviewed.
A variety of additional "dBase III plus" programmes were used to facilitate data analysis by recoding some fields and producing new files for specific purposes e.g. first episodes of attendance for eliciting risk factors, and files containing dichotomous variables for logistic regression. The appropriate files were then used for logistic regression using SPSS/ PC+Version 3.1, or tabular crude or stratified analysis using "Epi Info". 9 For assessment of risk factors, logistic regression analysis was confined to first episodes of attendance to avoid biases from multiple attenders. For assessment of selective screening criteria all episodes of attendance were considered and criteria, obtainable by history alone, were progressively added, in order of decreasing correlation, until at least 90% of positive cases were included by the selective screening criteria. For each set of criteria, the proportion of the target population which would be tested and the overall yield in the sample were also determined. Confidence limits for odds ratios from 2 x 2 tables were calculated using Cornfield fig 1   (for chlamydia) and fig 2 (for gonorrhoea) .
Factors associated with genital chlamydial and gonococcal infection in females those missed by the screening process continue to spread infection throughout the community.'6 It is difficult to define the minimum proportion of cases to be detected because individuals differ greatly in the extent to which they continue to transmit infection and requirements may differ in different environments. Several studies`7`9 have produced screening guidelines which elicit at least 90% of infections in the population tested, and this level of detection seems a reasonable target, as the spread rate from more than 10% of infected individuals could be quite substantial. Although first episodes of attendance were used for risk factor assessment to avoid bias from multiple attenders, consideration of all attendances is necessary for defining screening criteria. The yields of both chlamydia and gonorrhoea were only marginally less when all attendances were considered, and 19% of chlamydia and 15% of gonorrhoea cases were detected after the first attendance (table 1) . Correlates of infection may be detected from a patient's history (for example, age, number of sexual partners, symptoms), from examination (such as induced bleeding from the cervix, cervical ectropion) and from laboratory investigations (for example concurrent gonococcal infection). Whereas all these variables are useful in developing predictive models and guidelines for epidemiologic treatment, some cannot be used (for example laboratory investigations) and others may not be feasible indicators (such as pelvic examination findings) to help a general practitioner decide whether to advise a patient to be tested for chlamydia. In practice the clinician requires guidelines which involve information available before the patient is asked to undergo a genital examination.
As many factors are associated with infection and some may be interrelated, univariate analysis is often misleading. For The actual contribution of any predictor to the proportion of positives detected will be influenced by the magnitude of the association and the frequency of the predictor in the population. Thus a predictor which produces a relative risk of even 10-20 may not be useful if only 1-2% of the target population has this characteristic. In practice variables linked to less than 15% or more than 85% of the cases of infection are of limited value as selective screening criteria.
The approach in the present study was to add progressively criteria, in order of decreasing correlation, until at least 90% of positives: were included by the selective screening guidelines. For each set of criteria, the proportion of the target population which would be tested was also determined. The difference in percentage of tests required and percentage of positives obtained is a reflection of the degree to which the yield will be increased compared with the yield in the unselected population (the increased yield ratio).
For gonorrhoea, testing Aborigines, STD contacts and women under 25 detects 91% of positives, eliminates the need for 42% of tests and results in an increased yield ratio of 1.5. For chlamydia, selective criteria were less satisfactory. Testing women under 25, STD contacts and those using oral contraceptives detects 91% of positives, but eliminates only 29% of tests and results in an increased yield ratio of 1-3. Screening all women under the age of 30 produces a similar outcome (fig 2) . Some other studies 17-1 9 have developed screening guidelines for detecting at least 90% of chlamydia infections with more satisfactory increased yield ratios of 1.4 -1.8, but many others have been less successful,20-22 often finding age alone as predictive as multiple variables. As the epidemiology of infection obviously varies in different locations, empirical guidelines need to be developed for diverse settings. Some factors influencing the epidemiology of infection will be the health-seeking behaviour of individuals (i.e. how readily they respond to symptoms or seek screening when asymptomatic), the degree to which clinicians screen high risk individuals, or ensure treatment of sexual contacts of infected patients, the relative contribution of casual and commercial sex (which usually implies individuals with a large number of sexual partners) to the sexual activity of a community, sexual preference and sexual practice patterns, the use of prophylaxis and recidivism patterns (that is, the numbers and characteristics of individuals with repeated infections). (2) Selective criteria should cover at least 90% of the infected population and result in a substantial increase in yield (preferably an increased yield ratio of at least 1 f5).
